Catalyst Wire Dossier Catalyst Wire Dossier

Rexulti (brexpiprazole)

brexpiprazole · Otsuka Pharmaceutical; H. Lundbeck A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rexulti (brexpiprazole), covering 2017-06-26 to 2017-06-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment [Phase 3]

See pricing